Matthew J Akiyama1, Fatos Kaba1, Zachary Rosner1, Howard Alper1, Robert S Holzman1, Ross MacDonald1. 1. Matthew J. Akiyama and Robert S. Holzman are with the Division of Infectious Diseases, New York University School of Medicine, New York. Fatos Kaba, Zachary Rosner, Howard Alper, and Ross MacDonald are with the New York City Department of Health and Mental Hygiene, Bureau of Correctional Health Services, Queens, NY.
Abstract
OBJECTIVES: To examine uptake of screening for all individuals born between 1945 and 1965 (referred to by the Centers for Disease Control and Prevention as the "birth cohort") and outline preliminary HCV prevalence data in the New York City jail system. METHODS: Data were extracted from electronic health records for all individuals screened for HCV between June 13, 2013, and June 13, 2014, in New York City jails. We used the Abbott EIA 2.0 HCV antibody assay for testing. RESULTS: In the year of study, 56 590 individuals were incarcerated; 15.1% were born between 1945 and 1965, and 84.6% were born after 1965. HCV screening was completed for 64.1% of the birth cohort and for 11.1% born after 1965, with 55.1% and 43.8% of cases found in these groups, respectively. The overall seropositivity rate was 20.6%. CONCLUSIONS: Birth cohort screening in a large jail system identified many HCV cases, but HCV infection was common among younger age groups. PUBLIC HEALTH IMPLICATIONS: Universal screening may be warranted pending further study including cost-effectiveness analyses.
OBJECTIVES: To examine uptake of screening for all individuals born between 1945 and 1965 (referred to by the Centers for Disease Control and Prevention as the "birth cohort") and outline preliminary HCV prevalence data in the New York City jail system. METHODS: Data were extracted from electronic health records for all individuals screened for HCV between June 13, 2013, and June 13, 2014, in New York City jails. We used the Abbott EIA 2.0 HCV antibody assay for testing. RESULTS: In the year of study, 56 590 individuals were incarcerated; 15.1% were born between 1945 and 1965, and 84.6% were born after 1965. HCV screening was completed for 64.1% of the birth cohort and for 11.1% born after 1965, with 55.1% and 43.8% of cases found in these groups, respectively. The overall seropositivity rate was 20.6%. CONCLUSIONS: Birth cohort screening in a large jail system identified many HCV cases, but HCV infection was common among younger age groups. PUBLIC HEALTH IMPLICATIONS: Universal screening may be warranted pending further study including cost-effectiveness analyses.
Authors: Sarah Larney; Madeline K Mahowald; Nicholas Scharff; Timothy P Flanigan; Curt G Beckwith; Nickolas D Zaller Journal: Am J Public Health Date: 2014-04-17 Impact factor: 9.308
Authors: Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; Chong-Gee Teo; Amy Jewett; Brittney Baack; David B Rein; Nita Patel; Miriam Alter; Anthony Yartel; John W Ward Journal: MMWR Recomm Rep Date: 2012-08-17
Authors: Anne S Spaulding; Arthur Y Kim; Amy Jo Harzke; Jean C Sullivan; Benjamin P Linas; Arthur Brewer; Jeff Dickert; Barbara H McGovern; Lara B Strick; Robert Trestman; Warren J Ferguson Journal: Top Antivir Med Date: 2013 Feb-Mar
Authors: Joseph J Amon; Richard S Garfein; Linda Ahdieh-Grant; Gregory L Armstrong; Lawrence J Ouellet; Mary H Latka; David Vlahov; Steffanie A Strathdee; Sharon M Hudson; Peter Kerndt; Don Des Jarlais; Ian T Williams Journal: Clin Infect Dis Date: 2008-06-15 Impact factor: 9.079
Authors: Megan G Hofmeister; Elizabeth M Rosenthal; Laurie K Barker; Eli S Rosenberg; Meredith A Barranco; Eric W Hall; Brian R Edlin; Jonathan Mermin; John W Ward; A Blythe Ryerson Journal: Hepatology Date: 2018-11-06 Impact factor: 17.425
Authors: Matthew J Akiyama; Fatos Kaba; Zachary Rosner; Howard Alper; Aimee Kopolow; Alain H Litwin; Homer Venters; Ross MacDonald Journal: Public Health Rep Date: 2016-12-14 Impact factor: 2.792
Authors: Matthew J Akiyama; Jonathan Ross; Fatimah Rimawi; Aaron Fox; Alison O Jordan; Janet Wiersema; Alain H Litwin; Fatos Kaba; Ross MacDonald Journal: PLoS One Date: 2020-12-02 Impact factor: 3.240
Authors: Sara A Miller-Archie; Sarah C Walters; Angelica Bocour; Miranda S Moore; Ellen Wiewel; Tejinder Singh; Sungwoo Lim Journal: J Infect Dis Date: 2022-10-07 Impact factor: 7.759